Ninety One UK Ltd Has $42.75 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Ninety One UK Ltd grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 16.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,201,198 shares of the medical instruments supplier's stock after acquiring an additional 166,963 shares during the period. Ninety One UK Ltd owned 0.57% of DENTSPLY SIRONA worth $42,751,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP raised its position in DENTSPLY SIRONA by 83.1% in the 1st quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier's stock worth $270,829,000 after purchasing an additional 2,497,773 shares during the last quarter. Norges Bank bought a new position in DENTSPLY SIRONA in the 4th quarter worth approximately $60,861,000. Lazard Asset Management LLC raised its position in DENTSPLY SIRONA by 85.0% in the 4th quarter. Lazard Asset Management LLC now owns 2,992,857 shares of the medical instruments supplier's stock worth $95,292,000 after purchasing an additional 1,375,285 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in DENTSPLY SIRONA by 18.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 7,802,326 shares of the medical instruments supplier's stock worth $306,476,000 after purchasing an additional 1,224,984 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. grew its holdings in DENTSPLY SIRONA by 25.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 5,083,334 shares of the medical instruments supplier's stock worth $161,854,000 after acquiring an additional 1,030,275 shares during the period. Institutional investors own 95.70% of the company's stock.

Wall Street Analysts Forecast Growth

XRAY has been the subject of a number of analyst reports. StockNews.com raised shares of DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Friday, January 19th. Barrington Research reaffirmed an "outperform" rating and set a $41.00 target price on shares of DENTSPLY SIRONA in a report on Thursday. Leerink Partnrs reaffirmed an "outperform" rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Piper Sandler lifted their target price on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a "neutral" rating in a report on Friday, January 12th. Finally, SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a report on Monday, February 26th. They set an "outperform" rating and a $42.00 target price for the company. Three research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $39.50.

DENTSPLY SIRONA Trading Up 0.2 %

Shares of XRAY stock traded up $0.06 on Friday, hitting $30.50. The stock had a trading volume of 1,841,611 shares, compared to its average volume of 3,396,885. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $43.24. The firm has a market cap of $6.32 billion, a P/E ratio of -49.19, a PEG ratio of 1.23 and a beta of 0.98. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55. The company has a fifty day moving average price of $32.79 and a two-hundred day moving average price of $32.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. The company had revenue of $1.01 billion during the quarter, compared to analyst estimates of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The firm's revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.46 EPS. As a group, analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. This is a boost from DENTSPLY SIRONA's previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a yield of 2.10%. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA's payout ratio is currently -103.23%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.